Clinical Response Predictive Model for Omalizumab in Moderate-to-Severe Asthma Patients

Figure 2

Quantitative distribution change of FEV1, FeNo, ACT scores, and MiniAQLQ scores before and after omalizumab treatment: (a) FEV1; (b) FeNo; (c) ACT scores; (d) MiniAQLQ scores.

(a)

(b)

(c)

(d)